Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 5/20 | 0.75 |
| ▸ | CA1 | P00915 | 5/20 | 0.75 |
| ▸ | CA2 | P00918 | 5/20 | 0.75 |
| ▸ | CA7 | P43166 | 5/20 | 0.75 |
| ▸ | CA9 | Q16790 | 5/20 | 0.75 |
| ▸ | CA14 | Q9ULX7 | 5/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.59 |
| ▸ | ESR1 | P03372 | 2/20 | 0.59 |
| ▸ | TSHR | P16473 | 2/20 | 0.59 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.59 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.59 |
| ▸ | KDR | P35968 | 1/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | EGFR | P00533 | 3/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.48 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3063884 | 0.90 | CA12 (0.71) | CA12CA1CA2CA7CA9 | |
| SCHEMBL30456970 | 0.90 | CA12 (0.71) | CA12CA1CA2CA7CA9 | |
| SCHEMBL13286843 | 0.89 | CA12 (0.73) | CA12CA1CA2CA7CA9 | |
| SCHEMBL4594973 | 0.89 | CA12 (0.69) | CA12CA1CA2CA7CA9 | |
| SCHEMBL10569979 | 0.88 | ALDH1A1 (0.65) | CA12CA1CA2CA7CA9 | |
| SCHEMBL17107306 | 0.87 | CA12 (0.67) | CA12CA1CA2CA7CA9 | |
| SCHEMBL13422476 | 0.87 | CA12 (0.67) | CA12CA1CA2CA7CA9 | |
| SCHEMBL10581365 | 0.87 | CA12 (0.67) | CA12CA1CA2CA7CA9 | |
| SCHEMBL495935 | 0.87 | CA12 (0.67) | CA12CA1CA2CA7CA9 | |
| SCHEMBL31125314 | 0.87 | CA12 (0.67) | CA12CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119843294-A | Preparation method of axial chiral biaryl diphenol derivative | 江苏信和生物医药有限公司 | 2025-04-18 | — | — | CN | disclosed |
| EP-2222755-B1 | LAYER CONFIGURATION WITH IMPROVED STABILITY TO SUNLIGHT EXPOSURE | AGFA GEVAERT NV (BE) | 2016-10-05 | — | — | EP | disclosed |
| EP-2079792-B1 | LAYER CONFIGURATION WITH IMPROVED STABILITY TO SUNLIGHT EXPOSURE | AGFA GEVAERT NV (BE) | 2015-08-05 | — | — | EP | disclosed |
| CN-102958361-A | Herbicidal compositions | BASF SE | 2013-03-06 | — | — | CN | disclosed |
| US-7820078-B2 | Layer configuration with improved stability to sunlight exposure | AGFA GRAPHICS, N.V. (BE) | 2010-10-26 | — | — | US | disclosed |
| US-7670505-B2 | Compounds comprising 2,6-naphthyl groups | BASF AKTIENGESELLSCHAFT (DE) | 2010-03-02 | — | — | US | disclosed |
| US-7670505-B2 | Compounds comprising 2,6-naphthyl groups | BASF AKTIENGESELLSCHAFT (DE) | 2010-03-02 | — | — | US | disclosed |
| US-20090148722-A1 | LAYER CONFIGURATION WITH IMPROVED STABILITY TO SUNLIGHT EXPOSURE | AGFA-GEVAERT (BE) | 2009-06-11 | — | — | US | disclosed |
| US-20080290324-A1 | LAYER CONFIGURATION WITH IMPROVED STABILITY TO SUNLIGHT EXPOSURE | AGFA-GEVAERT N.V. (BE) | 2008-11-27 | — | — | US | disclosed |
| US-20080221289-A1 | Compounds Comprising 2,6-Naphthyl Groups | BASF AKTIENGESELLSCHAFT (DE) | 2008-09-11 | — | — | US | disclosed |
| US-20080221289-A1 | Compounds Comprising 2,6-Naphthyl Groups | BASF AKTIENGESELLSCHAFT (DE) | 2008-09-11 | — | — | US | disclosed |
| WO-2003075882-A2 | METHOD OF DEPIGMENTING SKIN AND HAIRS | GHISALBERTI CARLO (BR) | 2003-09-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080221289-A1 | Compounds Comprising 2,6-Naphthyl Groups | SCO2, MT-CO1, CBR1 | CA12 581/4885CA1 512/4885CA2 810/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.